The total return over the past 12 months is -25.47% vs. +16.94% for the S&P 500. So far it's up -27.25% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (25.47%) | +32.96% | (15.93%) | +1.80% | (9.79%) | (19.05%) |
| Total Return CAGR | (25.47%) | +32.96% | (15.93%) | +1.80% | (9.79%) | (19.05%) |
| Revenue CAGR | +24.20% | +19.28% | +16.99% | +26.79% | +15.27% | +17.87% |
| Net Income CAGR | +30.82% | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | +28.05% | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | (133.10%) | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | (133.10%) | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Nephros, Inc. (NEPH)
| Year | Start price | End price | NEPH Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $4.88 | $3.55 | (27.25%) | +14.51% | (41.76%) |
| 2025 | $1.47 | $4.88 | +231.97% | +17.72% | +214.25% |
| 2024 | $3.46 | $1.47 | (57.51%) | +24.89% | (82.40%) |
| 2023 | $1.16 | $3.46 | +198.28% | +26.19% | +172.09% |
| 2022 | $5.90 | $1.16 | (80.34%) | (18.17%) | (62.17%) |
| 2021 | $8.58 | $5.90 | (31.24%) | +28.74% | (59.98%) |
| 2020 | $9.95 | $8.58 | (13.77%) | +18.37% | (32.14%) |
| 2019 | $5.13 | $9.95 | +93.96% | +31.22% | +62.74% |
| 2018 | $4.05 | $5.13 | +26.67% | (4.56%) | +31.23% |
| 2017 | $3.33 | $4.05 | +21.62% | +21.70% | (0.08%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
